Literature DB >> 15994066

Inhibition of amyloid fibril formation of beta-amyloid peptides via the amphiphilic surfactants.

Steven S-S Wang1, Ya-Ting Chen, Shang-Wei Chou.   

Abstract

Beta-amyloid peptide (A beta) is the major proteinacious constituent of senile plaques in Alzheimer's disease and is believed to be responsible for the neurodegeneration process associated with the disease. While the actual size of the aggregated species responsible for A beta neurotoxicity and fibrillogenesis mechanism(s) remain unknown, retardation of A beta aggregation still holds assurance as an effective strategy in reducing A beta-elicited toxicity. The research presented here is aimed at examining the inhibitory effect of two amphiphilic surfactants, di-C6-PC and di-C7-PC, on the in vitro fibrillogenesis process of A beta(1--40) peptides at physiological pH (pH 7.2). Using ThT-induced fluorescence, turbidity, Congo red binding, and circular dichroism spectroscopy studies, our research demonstrated that the inhibition of A beta(1--40) fibril formation was di-C6-PC and di-C7-PC concentration-dependent. The best inhibitory action on fibril formation was observed when A beta was incubated with di-C7-PC at 100 microM over time. We believe that the outcome from this work will aid in the development and/or design of potential inhibitory agents against amyloid formation associated with Alzheimer's and other amyloid diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994066     DOI: 10.1016/j.bbadis.2005.05.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Investigation of the noncovalent interactions between anti-amyloid agents and amyloid beta peptides by ESI-MS.

Authors:  Eric Martineau; Janna M de Guzman; Lioudmila Rodionova; Xianqi Kong; Paul M Mayer; Ahmed M Aman
Journal:  J Am Soc Mass Spectrom       Date:  2010-05-31       Impact factor: 3.109

Review 2.  A brief overview of amyloids and Alzheimer's disease.

Authors:  Sian-Yang Ow; Dave E Dunstan
Journal:  Protein Sci       Date:  2014-07-30       Impact factor: 6.725

3.  Phenol red interacts with the protofibril-like oligomers of an amyloidogenic hexapeptide NFGAIL through both hydrophobic and aromatic contacts.

Authors:  Chun Wu; Hongxing Lei; Zhixiang Wang; Wei Zhang; Yong Duan
Journal:  Biophys J       Date:  2006-08-25       Impact factor: 4.033

4.  Inhibition of amyloid fibrillation of apo-carbonic anhydrase by flavonoid compounds.

Authors:  Ali Es-Haghi; Azadeh Ebrahim-Habibi
Journal:  J Biosci       Date:  2019-06       Impact factor: 1.826

Review 5.  Anti-amyloid Aggregation Activity of Natural Compounds: Implications for Alzheimer's Drug Discovery.

Authors:  Xian-Le Bu; Praveen P N Rao; Yan-Jiang Wang
Journal:  Mol Neurobiol       Date:  2015-06-23       Impact factor: 5.590

6.  Inhibition of beta-amyloid(1-40) Peptide Aggregation and Neurotoxicity by Citrate.

Authors:  Yong Hoon Park; Young-Jin Kim; Il Hong Son; Hyun Duk Yang
Journal:  Korean J Physiol Pharmacol       Date:  2009-08-31       Impact factor: 2.016

7.  Exploration of the mechanism for LPFFD inhibiting the formation of beta-sheet conformation of A beta(1-42) in water.

Authors:  Cao Yang; Xiaolei Zhu; Jinyu Li; Rongwei Shi
Journal:  J Mol Model       Date:  2010-01-05       Impact factor: 1.810

8.  Citrus bergamia Juice Extract Attenuates β-Amyloid-Induced Pro-Inflammatory Activation of THP-1 Cells Through MAPK and AP-1 Pathways.

Authors:  Monica Currò; Roberto Risitano; Nadia Ferlazzo; Santa Cirmi; Chiara Gangemi; Daniela Caccamo; Riccardo Ientile; Michele Navarra
Journal:  Sci Rep       Date:  2016-02-08       Impact factor: 4.379

Review 9.  Protein folding and aggregation into amyloid: the interference by natural phenolic compounds.

Authors:  Massimo Stefani; Stefania Rigacci
Journal:  Int J Mol Sci       Date:  2013-06-13       Impact factor: 5.923

10.  Identification and characterization of a compound from Cuminum cyminum essential oil with antifibrilation and cytotoxic effect.

Authors:  D Morshedi; T Salmani Kesejini; F Aliakbari; R Karami-Osboo; M Shakibaei; A Tayaranian Marvian; M Khalifeh; M Soroosh
Journal:  Res Pharm Sci       Date:  2014 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.